Check Out Our Meetup at Rutgers
On June 11-12, 2014, researchers from across the community met with IT professionals who are working to build enabling tools for data generation, acquisition, analysis, sharing, and security throughout the drug pipeline from discovery to patients.
Thank you to all of our Speakers, Attendees, Exhibitors and Volunteers! Special thanks goes to PCI Pharma, a division of PlanetConnect - we couldn't do it without you.
We're planning a great summer and fall- let us know what you're up to, and how you would like to get involved- committees are forming now to help build intriguing ways to communicate with your community!
Robert J. Boland, Directing Senior Manager of External Innovation R&D at Janssen Pharmaceuticals, led off with his Keynote: “Fostering External Alliances to Drive IT Innovation in Pharma”. He explained that the choices that we make, as well as the alliances and partnerships we build, will aid in driving pre-competitive innovation in IT and Pharma.
Through a short video, pictured above, Boland demonstrated how we can progress as an industry further together than alone. Though there are many challenges in building cooperative structures across the highly competitive and regulated pharma industry, shared direction can increase productivity as companies focus upon innovating technology, supporting scientific collaborations, externalizing internal technology, and building innovative external partnerships.
Janssen R&D has a new scientific data collaboration infrastructure which will aid in this information sharing as well as the TranSMART Knowledge Management Platform, which was created for externalizing internal technology. TranSMART was created by Johnson & Johnson, but is supported and seeing ongoing development from Janssen R&D.
Right: Robert J. Boland, Directing Senior Manager of External Innovation R&D,
Below: Bonnie Feldman, DDS, MBA, Chief Growth Officer, @drbonnie
Further addressing the changing environment for collaboration, Keynote Dr. Bonnie Feldman ---
"Not only do we have new technology that will help us, but we have a societal shift in thinking that's going to enable all of us to work together in new and different ways."
Focusing upon the growing needs of patients with autoimmune disorders, she noted that with the explosion of personal data and tracking devices, there is a "dream of personalized medicine in the future". She reminded those gathered that we’re beginning to see the innovations foreseen by Judy Jetson (link) becoming more accessible, yet there is much more work to do.
Currently, there are more than 50 million Americans that are suffering from over 90 autoimmune diseases, all of whom will benefit from advances in precision medicine. Through new forms of data, new approaches to research discovery and clinical trials, and new ways of sharing and collaboration, stakeholders are able to come together and fuel the war on autoimmune disease.
As principal of DrBonnie360, Bonnie Feldman, DDS, MBA, is an entrepreneurial dentist, a Wall Street analyst, and a digital health analyst and consultant. Recently, she has interviewed more than 150 digital health companies about their approaches to new technology.